TNGX 8-K 2026-10-23

Tango Therapeutics, Inc. (TNGX) 8-K dated 2026-10-23 — accession 0001193125-26-429423. This URL is the filing, not the TNGX hub.

Tango Therapeutics, Inc. (TNGX) is a biotechnology company listed on NASDAQ.

Tango Therapeutics, Inc. filed a 8-K on 2026-10-23. Accession 0001193125-26-429423.

Cached items: 7.01, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported TNGX revenue for 2025-12-31 was $62.4M. Net income was -$101.6M. Revenue was up 48.3% from 2024-12-31 to 2025-12-31. TNGX currently screens at market cap $5.36B.

Not investment advice. The TNGX SEC hub lists recent forms. The stock page is the research view.